| Literature DB >> 19216785 |
Matthew S Lebo1, Laura E Sanders, Fengzhu Sun, Michelle N Arbeitman.
Abstract
BACKGROUND: Drosophila melanogaster undergoes a complete metamorphosis, during which time the larval male and female forms transition into sexually dimorphic, reproductive adult forms. To understand this complex morphogenetic process at a molecular-genetic level, whole genome microarray analyses were performed.Entities:
Mesh:
Year: 2009 PMID: 19216785 PMCID: PMC2656526 DOI: 10.1186/1471-2164-10-80
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1The . The Drosophila sex determination hierarchy consists of a cascade of sex-specific alternatively spliced pre-mRNAs culminating in the production of sex-specific transcription factors encoded by doublesex (dsx) and fruitless P1 (fru P1). The primary determinate of sex is the X chromosome to autosomal chromosome (A) ratio. In females (X:A = 1), Sex Lethal (SXL) is produced and regulates the splicing of the pre-mRNA of transformer (tra), resulting in the production of TRA. TRA acts in conjunction with constitutively produced TRA-2, and regulates the alternative splicing of the pre-mRNAs of dsx and fru P1, leading to the production of the female-specific protein DSXF. In males (X:A = 0.5), SXL is not produced and dsx and fru P1 pre-mRNAs undergo default splicing, resulting in the production of the male sex-specific proteins DSXM and FRUM. In addition, in females SXL represses dosage compensation, the process by which transcription of genes on the single X chromosome in males is up-regulated to roughly equal that of the two X chromosomes in females.
Microarray experimental design for time course and sex hierarchy experiments.
| Wild type female (CS) | Reference | 3 | 0, 24, 48, 72, 96 | |
| Wild type male (CS) | Reference | 3 | 0, 24, 48, 72, 96 | |
| Reference | 3 | 0, 24, 48, 72, 96 | ||
| Reference | 3 | 0, 24, 48, 72, 96 | ||
| Wild type female (CS) | Wild type male (CS) | 4 | 48 | 7972 |
| Wild type female (Berlin) | Wild type male (Berlin) | 4 | 48 | |
| 4 | 48 | 420 | ||
| Wild type female (CS) | XX | 4 | 48 | 95 |
| Wild type female (CS) | XX | 4 | 48 | 173** |
| Wild type female (CS) | XX | 4 | 48 | 154 |
| Wild type male (CS) | XY | 4 | 48 | 155 |
Probes, numbers of replicates, and the time points assayed are listed for each experiment. Chromosomal sex is indicated by XX or XY. * Sex determination hierarchy experiments were all performed with a dye-swap design (see Methods). † The number of genes in each experiment that is significantly differentially expressed. ** The DSX set was defined with an additional statistical test to eliminate potential false-negatives resulting from exclusion in the TRA set. Therefore, a gene's inclusion in the DSX set is not necessarily contingent on its presence in the TRA set. For a description of the definition of the DSX set, see Results and Discussion and Methods.
Sex differentially expressed genes in somatic tissues during metamorphosis.
| 0 hr | Male | CR32777 | X | 24.1 | dosage compensation | |
| CG1441 | 2R | 2.5 | catalytic activity; binding | |||
| Female | CG4500 | 2L | 2.7 | mesoderm development | ||
| CG2559 | X | 2.3 | nutrient reservoir activity; oxygen transporter | |||
| CG6186 | X | 2.0 | iron ion transport; defense response | |||
| 24 hr | Male | CR32777 | X | 150.6 | dosage compensation | |
| CG9355 | X | 16.1 | wing morphogenesis | |||
| CG1368 | X | 5.0 | structural constituent of chorion | |||
| CG5823 | 3R | 4.9 | ubiquitin-protein ligase activity | |||
| CG31948 | 2L | 3.8 | protein modification process | |||
| CG4691 | 2L | 3.6 | unknown | |||
| CG5450 | 2L | 3.5 | microtubule motor activity | |||
| CG11350 | 3L | 3.2 | unknown | |||
| CG6372 | 3L | 3.0 | mushroom body development; proteolysis | |||
| CG10383 | 2L | 2.6 | binding | |||
| CG10701 | X | 2.2 | cytoskeletal protein binding; actin binding | |||
| CG2082 | 3R | 2.2 | unknown | |||
| CG11905 | 3L | 2.2 | hydrolase activity | |||
| CG15757 | X | 2.0 | structural constituent of cuticle | |||
| CG3416 | 2R | 2.0 | endopeptidase activity; cell proliferation | |||
| Female | CG2930 | X | 4.1 | oligopeptide transport | ||
| CG10650 | 2L | 3.2 | oxidoreductase activity | |||
| CG12290 | 3R | 2.4 | G-protein coupled receptor activity | |||
| CG14540 | 3R | 2.4 | unknown | |||
| CG16997 | 2L | 2.3 | serine-type endopeptidase activity | |||
| CG7045 | 3R | 2.3 | regulation of transcription; DNA binding | |||
| CG9634 | X | 2.3 | metalloendopeptidase activity | |||
| CG2759 | X | 2.3 | transmembrane receptor activity; eye pigment | |||
| CG8947 | 3L | 2.3 | cathepsin K activity; proteolysis | |||
| CG32695 | X | 2.3 | unknown | |||
| CG13586 | 2R | 2.2 | neuropeptide hormone activity | |||
| CG15312 | X | 2.1 | unknown | |||
| CG15369 | X | 2.1 | cysteine protease inhibitor activity | |||
| CG16865 | 2L | 2.0 | unknown | |||
| 48 hr | Male | CR32777 | X | 232.8 | dosage compensation | |
| CG31988 | 2L | 5.2 | zinc ion binding | |||
| CG7088 | X | 2.3 | gliogenesis | |||
| CG1368 | X | 2.3 | structural constituent of chorion | |||
| CG9914 | X | 2.0 | fatty acid metabolic process | |||
| CG31948 | 2L | 2.0 | protein modification process | |||
| Female | CG15757 | X | 5.0 | structural constituent of cuticle | ||
| CG7756 | 3R | 5.0 | unfolded protein binding; ATP binding | |||
| CG6416 | 3L | 3.6 | mesoderm development; protein binding | |||
| CG1441 | 2R | 3.5 | catalytic activity; binding | |||
| CG12523 | 3L | 3.1 | unknown | |||
| CG7635 | X | 2.8 | unknown | |||
| CG32982 | 2L | 2.8 | unknown | |||
| CG8745 | 3L | 2.6 | arginine catabolic process to glutamate | |||
| CG33756 | 3L | 2.5 | spermatogenesis; oogenesis | |||
| CG12009 | 3L | 2.5 | chitin binding; chitin metabolism | |||
| CG2559 | X | 2.4 | nutrient reservoir activity; oxygen transporter | |||
| CG7367 | 2L | 2.3 | phagocytosis; lipid metabolic process | |||
| CG15369 | X | 2.2 | cysteine protease inhibitor activity | |||
| CG31901 | 2L | 2.2 | unknown | |||
| CG13360 | X | 2.1 | unknown | |||
| CG10589 | 3L | 2.1 | unknown | |||
| 72 hr | Male | CR32777 | X | 147.6 | dosage compensation | |
| CG7191 | 2L | 2.1 | unknown | |||
| CG13503 | 2.1 | actin filament organization | ||||
| Female | CG11591 | 3L | 6.2 | unknown | ||
| CG31948 | 2L | 5.5 | protein modification process | |||
| CG32690 | X | 5.1 | unknown | |||
| CG7738 | 4.0 | |||||
| CG10589 | 3L | 3.8 | unknown | |||
| CG9975 | 2R | 3.7 | unknown | |||
| CG15757 | X | 3.7 | structural constituent of cuticle | |||
| CG31639 | 2L | 3.3 | unknown | |||
| CG4691 | 2L | 3.1 | unknown | |||
| CG8871 | 2L | 3.1 | elastase activity; serine-type endopeptidase | |||
| CG7322 | X | 3.0 | oxidoreductase activity | |||
| CG1179 | 3L | 2.9 | lysozyme activity | |||
| CG17118 | 2L | 2.6 | dendrite morphogenesis | |||
| CG8813 | 2L | 2.6 | unknown | |||
| CG13360 | X | 2.4 | unknown | |||
| CG10809 | 3L | 2.4 | unknown | |||
| CG5446 | 2L | 2.4 | unknown | |||
| CG14540 | 3R | 2.3 | unknown | |||
| CG11765 | 2R | 2.3 | glutathione peroxidase activity | |||
| CG31901 | 2L | 2.2 | unknown | |||
| CG10325 | 3R | 2.2 | transcription factor; organismal development | |||
| CG15369 | X | 2.1 | cysteine protease inhibitor activity | |||
| CG2559 | X | 2.1 | nutrient reservoir activity; oxygen transporter | |||
| CG12250 | 3R | 2.1 | unknown | |||
| CG17244 | 3R | 2.0 | unknown | |||
| CG1998 | X | 2.0 | C-4 methylsterol oxidase activity | |||
| 96 hr | Male | CR32777 | X | 325.5 | dosage compensation | |
| CG31988 | 2L | 7.8 | zinc ion binding | |||
| CG6372 | 3L | 5.7 | mushroom body development; proteolysis | |||
| CG5450 | 2L | 4.1 | microtubule motor activity | |||
| CG11798 | 2R | 4.1 | nervous system development; transcription | |||
| CG17829 | X | 3.8 | zinc ion binding | |||
| CG1774 | 3R | 3.7 | catalytic activity; nucleotide binding | |||
| CG31029 | 3R | 3.6 | unknown | |||
| CG13164 | 2R | 3.5 | unknown | |||
| CG1179 | 3L | 3.3 | lysozyme activity | |||
| CG4691 | 2L | 3.3 | unknown | |||
| CG3035 | X | 3.1 | neurotransmitter secretion; synaptic vesicle | |||
| CG4300 | 3L | 2.7 | spermidine synthase activity | |||
| CG7228 | 2L | 2.7 | scavenger receptor activity | |||
| CG1772 | 2R | 2.7 | cyclin-dependent protein kinase inhibitor | |||
| CG8813 | 2L | 2.6 | unknown | |||
| CG7104 | 3R | 2.4 | structural constituent of ribosome | |||
| CG12237 | X | 2.4 | phosphoric monoester hydrolase activity | |||
| CG7738 | 2.4 | unknown | ||||
| CG9975 | 2R | 2.3 | unknown | |||
| CG17180 | 3L | 2.3 | vesicle-mediate transport | |||
| CG12009 | 3L | 2.2 | chitin binding | |||
| CG8931 | X | 2.2 | binding; transport | |||
| CG17230 | 3R | 2.2 | unknown | |||
| CG31163 | 3R | 2.1 | SH3/SH2 adaptor activity | |||
| CG9543 | 2L | 2.1 | retrograde vesicle-mediated transport | |||
| CG30392 | 2R | 2.1 | glycolipid transporter activity | |||
| CG31639 | 2L | 2.1 | ||||
| CG5343 | 2L | 2.0 | muscle development; dendrite morphogenesis | |||
| CG4845 | 3R | 2.0 | phagocytosis; immune response | |||
| CG7756 | 3R | 2.0 | unfolded protein binding; ATP binding | |||
| Female | CG1368 | X | 3.9 | structural constituent of chorion | ||
| CG2559 | X | 3.0 | nutrient reservoir activity; oxygen transporter | |||
| CG32031 | 3L | 3.0 | arginine kinase activity | |||
| CG15369 | X | 2.4 | cysteine protease inhibitor activity | |||
| CG32695 | X | 2.4 | unknown | |||
| CG7816 | 3R | 2.3 | metal ion transmembrane transporter | |||
| CG2759 | X | 2.2 | transmembrane receptor activity; eye pigment | |||
| CG32850 | 4 | 2.1 | protein binding; zinc ion binding | |||
| CG14717 | 3R | 2.0 | hydrolase activity | |||
| CG17118 | 2L | 2.0 | dendrite morphogenesis |
Significant somatic, sex-differential expression determined using F-tests, and a t-test of means comparing expression data from male and female tud progeny. All genes listed had at least a 2-fold difference in transcript abundance between the sexes. For the full lists of sex-differentially expressed genes, see Additional file 3. * Annotation symbol from Flybase. † Chromosomal arm on which the gene is located. ‡ Fold change difference between the sexes. ξGO annotations for each gene as listed in Flybase.
Figure 2The number of genes with somatic sex-differential transcript levels differs across metamorphosis. The abscissa indicates the five time points during metamorphosis examined (0, 24, 48, 72, and 96 hour APF). The ordinate indicates the number of somatic, sex-differentially expressed genes, as identified by F-tests, q < 0.15, for sex or sex-time interaction terms, and a t-test of the means (q < 0.15), on the gene expression data of male and female tud progeny. Genes with female- and male-biased expression are shown in grey and black, respectively.
Figure 3Clusters of genes with similar expression profiles in somatic tissues during metamorphosis. Clusters were generated using gene expression data from male and female tud progeny at five time points during metamorphosis, indicated at top of clustergram. Expression profiles for each cluster were generated by averaging the gene expression data at each time point for every gene in the cluster in both sexes. Yellow and blue indicates high and low levels of expression compared to a common reference, respectively. To the right of the clustergram, black and grey indicates a cluster in which gene expression is at a peak (enriched) or at a trough (depleted), respectively, relative to the average expression value across all time points. Clusters are at a peak or trough of expression if average expression was 2/3 of a standard deviation above or below the mean expression value of the five time points, respectively. Functional annotation represents functional categories that were overrepresented among the genes in the cluster, as determined by the program DAVID (P < 0.05 [22]).
Figure 4Expression profiles of genes expressed in the male and female germline during metamorphosis. Expression profiles were generated by averaging the gene expression data of all genes that have high expression in the male or female germline at each time point. The data for these genes for following genotypes were averaged separately: male tud progeny, female tud progeny, wild type (CS) males, and wild type (CS) females. Yellow and blue indicates high and low levels of expression compared to a common reference, respectively.
Figure 5Cluster of global expression profiles for Drosophila transcripts across metamorphosis. Dendrogram shows the similarity across transcriptional profiles at five time points during metamorphosis (0, 24, 48, 72, and 96 hour APF) for (A) male tud progeny (blue) and female tud progeny (red) and (B) male tud progeny, female tud progeny, wild type (CS) males (green), and wild type (CS) females (violet). Hierarchical clustering and Pearson correlation distance measure was used to group experiments based on their global expression profile using all expression data for annotated genes from each array. Values on each node represent the confidence of the separation (approximately unbiased P value) derived using multiscale bootstrap resampling and the program Pvclust [63].
Genes expressed downstream of DSX at 48 hour APF.
| Male | CG1342 | 3R | 6.0 | serine-type endopeptidase inhibitor activity | |
| CG15596 | 3R | 4.9 | unknown | ||
| CG12063 | 3R | 4.8 | unknown | ||
| CG13535 | 4.2 | unknown | |||
| CG17131 | X | 4.0 | unknown | ||
| CG32159 | 3L | 6.5 | unknown | ||
| CG32356 | 3L | 4.8 | lipoprotein binding; imaginal disc eversion | ||
| CG4386 | 2R | 4.5 | trypsin activity; proteolysis | ||
| CG9369 | X | 3.8 | cuticle pattern formation; epidermal cell differentiation | ||
| CG14925 | 2L | 3.4 | unknown | ||
| CG4702 | 3R | 3.3 | unknown | ||
| CG8420 | 3R | 3.2 | unknown | ||
| CG15013 | 3L | 3.1 | structural constituent of cuticle | ||
| CG1499 | 3R | 3.1 | unknown | ||
| CG10717 | 3L | 3.1 | unknown | ||
| CG6611 | 3L | 3.0 | unknown | ||
| CG14029 | 2L | 3.0 | transcription factor activity; bristle morphogenesis | ||
| CG13728 | 3L | 2.9 | unknown | ||
| CG15020 | 3L | 2.8 | structural constituent of cuticle | ||
| CG15643 | X | 2.8 | unknown | ||
| CG32354 | 3L | 2.7 | endopeptidase inhibitor activity | ||
| CG13078 | 2L | 2.7 | unknown | ||
| CG15589 | 3R | 2.7 | unknown | ||
| CG13209 | 2R | 2.7 | wing hair biogenesis; antennal morphogenesis | ||
| CG10898 | 3R | 2.5 | DNA repair | ||
| CG13059 | 3L | 2.3 | unknown | ||
| CG4844 | 2R | 2.3 | unknown | ||
| CG31637 | 2L | 2.2 | sulfotransferase activity; carbohydrate metabolism | ||
| CG11438 | 3L | 2.1 | phosphatidate phosphatase activity; lipid metabolism | ||
| CG10697 | 2L | 2.0 | catecholamine metabolism; learning and/or memory | ||
| CG32796 | X | 2.0 | ectoderm development; nervous system development | ||
| CG10249 | 2R | 2.0 | unknown | ||
| Female | CG6337 | 2R | 15.2 | cysteine-type endopeptidase activity | |
| CG31878 | 2L | 11.9 | structural constituent of cuticle | ||
| CG16884 | 2L | 11.0 | unknown | ||
| CG16885 | 2L | 10.2 | unknown | ||
| CG14752 | 2R | 9.0 | unknown | ||
| CG8927 | 3R | 7.5 | unknown | ||
| CG7330 | 3L | 6.7 | unknown | ||
| CG15251 | X | 6.5 | unknown | ||
| CG12164 | 2R | 6.1 | unknown | ||
| CG10264 | 3R | 6.0 | unknown | ||
| CG15884 | 3R | 5.9 | structural constituent of cuticle | ||
| CG32694 | X | 5.6 | unknown | ||
| CG16886 | 2L | 5.3 | unknown | ||
| CG3100 | X | 5.2 | neuronal pentraxin receptor activity | ||
| CG17058 | X | 5.2 | chitin binding; chitin metabolism | ||
| CG10175 | 3R | 4.9 | carboxylesterase activity; phosphopantetheine binding | ||
| CG30427 | 2R | 4.9 | oxidoreductase activity | ||
| CG11380 | X | 4.8 | unknown | ||
| CG15778 | X | 4.7 | unknown | ||
| CG17829 | X | 4.5 | nucleic acid binding; zinc ion binding | ||
| CG1441 | 2R | 4.3 | oxidoreductase activity | ||
| CG32645 | X | 4.3 | transferase activity | ||
| CG32036 | 3L | 4.2 | chitin binding; chitin metabolism | ||
| CG14052 | X | 4.1 | unknown | ||
| CG4163 | 2L | 4.1 | sensory organ development; steroid metabolism | ||
| CG3244 | 2L | 4.0 | sugar binding | ||
| CG32499 | X | 3.8 | chitin binding; chitin metabolism | ||
| CG32550 | X | 3.7 | unknown | ||
| CG10051 | 2R | 3.7 | unknown | ||
| CG13931 | 3L | 3.6 | unknown | ||
| CG9358 | 2R | 3.6 | protein kinase activity; gametogenesis | ||
| CG17707 | X | 3.5 | unknown | ||
| CG14534 | 2L | 3.5 | nutrient reservoir activity | ||
| CG13338 | 2R | 3.5 | structural constituent of cuticle | ||
| CG13138 | 2L | 3.5 | unknown | ||
| CG9021 | 2L | 3.4 | unknown | ||
| CG12023 | 3L | 3.4 | DNA binding | ||
| CG14770 | X | 3.4 | unknown | ||
| CG15322 | X | 3.3 | unknown | ||
| CG7031 | 3R | 3.3 | unknown | ||
| CG6131 | 3R | 3.3 | structural constituent of cuticle | ||
| CG14218 | X | 3.3 | serine-type endopeptidase activity | ||
| CG33299 | 2L | 3.3 | unknown | ||
| CG17777 | X | 3.2 | unknown | ||
| CG15055 | X | 3.2 | unknown | ||
| CG1561 | X | 3.1 | unknown | ||
| CG1702 | X | 3.0 | glutathione transferase activity; defense response | ||
| CG12057 | X | 2.9 | unknown | ||
| CG13616 | 3R | 2.9 | unknown | ||
| CG17032 | 3L | 2.9 | unknown | ||
| CG6592 | 3L | 2.9 | chymotrypsin activity; proteolysis | ||
| CG33342 | 3R | 2.8 | unknown | ||
| CG10112 | 2R | 2.8 | structural constituent of cuticle | ||
| CG8192 | 2R | 2.8 | unknown | ||
| CG5873 | 3R | 2.7 | peroxidase activity; defense response | ||
| CG3477 | 3R | 2.7 | peroxidase activity; phagocytosis, engulfment | ||
| CG14946 | 2L | 2.6 | oxidoreductase activity; binding | ||
| CG8756 | 3L | 2.6 | chitin deacetylase activity; open tracheal system | ||
| CG10939 | 2R | 2.5 | cell homeostasis; ion transport; olfactory behavior | ||
| CG7445 | 3L | 2.5 | muscle thick filament assembly | ||
| CG17052 | X | 2.5 | chitin binding; chitin metabolism | ||
| CG12449 | 3R | 2.5 | sugar binding; carbohydrate biosynthesis | ||
| CG6739 | 2L | 2.5 | unknown | ||
| CG13062 | 3L | 2.5 | unknown | ||
| CG5506 | 3L | 2.4 | unknown | ||
| CG33996 | 2R | 2.4 | unknown | ||
| CG7047 | 3L | 2.4 | unknown | ||
| CG9850 | 2R | 2.4 | metallopeptidase activity; cell proliferation | ||
| CG30101 | 2R | 2.4 | unknown | ||
| CG32145 | 3L | 2.4 | peptidase activity; signal transduction | ||
| CG4404 | X | 2.4 | DNA binding | ||
| CG4533 | 2R | 2.3 | embryonic development; protein folding | ||
| CG32816 | X | 2.3 | unknown | ||
| CG14191 | X | 2.3 | unknown | ||
| CG7135 | X | 2.2 | unknown | ||
| CG3254 | 2L | 2.2 | protein amino acid glycosylation | ||
| CG8358 | 3R | 2.1 | neprilysin activity; proteolysis; signal transduction | ||
| CG12523 | 3L | 2.1 | unknown | ||
| CG8624 | 3L | 2.1 | specific transcriptional repressor activity; development | ||
| CG9134 | 3L | 2.1 | sugar binding | ||
| CG9328 | 2L | 2.1 | unknown | ||
| CG32209 | 3L | 2.1 | chitin metabolism; tracheal system development | ||
| CG4484 | 3L | 2.1 | sucrose:hydrogen symporter activity | ||
| CG16820 | 2L | 2.1 | unknown | ||
| CG9990 | 3R | 2.1 | ATPase activity; transporter activity; ATP binding | ||
| CG13188 | 2R | 2.1 | unknown | ||
| CG32171 | 3L | 2.0 | transcription factor activity; development |
All genes listed had at least a 2.0-fold difference in transcript abundance when comparing XX dsxpseudomales to wild type females at 48 hour APF. For the full lists of genes regulated as a consequence of dsx, see Additional file 10. * Annotation symbol from Flybase. † Chromosomal arm on which the gene is located. ‡ Fold change difference between the sexes. ξGO annotations for each gene as listed in Flybase.